Children between the ages of 13 and 17 who have the following conditions
-Schizophrenia or Bipolar
-Major depressive with bipolar
-Autism
Study Medication: Lumateperone
The following documentation must be provided:
-Parent's driver's license
-Child's passport
-Child's birth certificate
-Child's medical records
Compensation $150 each visit
Subjects aged 18 and older who have been diagnosed with Tardive Dyskinesia (TD) or who are experiencing involuntary movements .Subjects with the following medical diagnosis:
-Schizophrenia or schizoaffective disorder
-Bipolar disorder
Participants must either:
Be receiving deutetrabenazine or deutetrabenazine XR at daily doses for at least 8 weeks prior to screening
or have previously discontinues valbenazine.
Study medication: Valbenazine
Compensation $144 each visit